Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Madrigal Pharmaceuticals Inc (MDGL)

Madrigal Pharmaceuticals Inc (MDGL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 6,727,073
  • Shares Outstanding, K 21,810
  • Annual Sales, $ 0 K
  • Annual Income, $ -373,630 K
  • EBIT $ -548 M
  • EBITDA $ -545 M
  • 60-Month Beta -0.42
  • Price/Sales 83.32
  • Price/Cash Flow N/A
  • Price/Book 8.23

Options Overview Details

View History
  • Implied Volatility 55.34% ( -0.29%)
  • Historical Volatility 47.60%
  • IV Percentile 39%
  • IV Rank 12.07%
  • IV High 156.35% on 02/23/24
  • IV Low 41.48% on 08/19/24
  • Put/Call Vol Ratio 0.33
  • Today's Volume 451
  • Volume Avg (30-Day) 450
  • Put/Call OI Ratio 0.71
  • Today's Open Interest 32,405
  • Open Int (30-Day) 31,815

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 16 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate -4.53
  • Number of Estimates 7
  • High Estimate -3.86
  • Low Estimate -5.12
  • Prior Year -5.68
  • Growth Rate Est. (year over year) +20.25%

Price Performance

See More
Period Period Low Period High Performance
1-Month
289.80 +6.43%
on 12/18/24
351.80 -12.33%
on 11/25/24
-8.65 (-2.73%)
since 11/20/24
3-Month
200.63 +53.74%
on 10/23/24
368.29 -16.25%
on 11/07/24
+74.95 (+32.10%)
since 09/20/24
52-Week
168.25 +83.33%
on 02/09/24
368.29 -16.25%
on 11/07/24
+87.40 (+39.54%)
since 12/20/23

Most Recent Stories

More News
Novo Nordisk: A New Boost for GLP-1 Sales on the Horizon

Novo Nordisk A/S is moving closer to adding more sales for its blockbuster GLP-1 drug semaglutide to treat a chronic liver disease.

NVO : 85.00 (-17.83%)
MDGL : 308.44 (+5.12%)
LLY : 767.76 (+1.35%)
Insider Sale: Director at $MDGL (MDGL) Sells 520 Shares

FRED B CRAVES, a director at $MDGL ($MDGL), sold 520 shares of the company on 12-03-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately 4.5% of their shares....

MDGL : 308.44 (+5.12%)
Billionaire Ken Griffin Invested $93 Million of Citadel's Portfolio in a Stock That Could Rocket 105% Higher, According to a Wall Street Analyst

Ken Griffin started the Citadel hedge fund in 1990. It's become so successful that his net worth has risen to a stunning $46 billion.

VKTX : 42.25 (+1.83%)
RILY : 4.98 (-2.16%)
NVO : 85.00 (-17.83%)
MDGL : 308.44 (+5.12%)
LLY : 767.76 (+1.35%)
3 Reasons Why Buying Madrigal Pharmaceuticals Today Is a Wise Move

When a company's shares shoot up 82% in 12 months, investors clearly think it's a good time to be a shareholder -- and that's exactly what's happened to the stock of Madrigal Pharmaceuticals (NASDAQ: MDGL)...

MDGL : 308.44 (+5.12%)
Zacks Industry Outlook Madrigal, Corcept, Catalyst Larimar and Theravance

For Immediate ReleaseChicago, IL – November 11, 2024 – Today, Zacks Equity Research like Madrigal Pharmaceuticals MDGL, Corcept Therapeutics CORT, Catalyst Pharmaceuticals CPRX, Larimar Therapeutics...

CORT : 51.40 (+0.49%)
TBPH : 9.59 (-1.44%)
MDGL : 308.44 (+5.12%)
LRMR : 4.01 (+0.75%)
CPRX : 21.27 (-0.89%)
1 Growing Biotech Stock to Buy Today With $1,000 and Hold for 5 Years or More

There's a bright future ahead for this company.

MDGL : 308.44 (+5.12%)
5 Small Drug Stocks to Buy as Trump Gets Re-Elected

The drug industry witnessed major policy changes during Joe Biden's four-year term as U.S. President, including the historic Inflation Reduction Act (“IRA”). With Donald Trump’s reelection, the biotech...

CORT : 51.40 (+0.49%)
TBPH : 9.59 (-1.44%)
MDGL : 308.44 (+5.12%)
LRMR : 4.01 (+0.75%)
CPRX : 21.27 (-0.89%)
Madrigal Pharmaceuticals, Inc. Announces Participation at Three Upcoming Investor Conferences

MDGL : 308.44 (+5.12%)
Madrigal: Q3 Earnings Snapshot

Madrigal: Q3 Earnings Snapshot

MDGL : 308.44 (+5.12%)
Madrigal Pharmaceuticals Reports Third-Quarter 2024 Financial Results and Provides Corporate Updates

MDGL : 308.44 (+5.12%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Madrigal Pharmaceuticals, Inc. is engaged in developing small-molecule drugs addressing cardiovascular and metabolic diseases. Its products pipeline include MGL-3196, an orally administered liver-directed thyroid hormone receptor-' agonist that is used for the treatment of NASH, dyslipidemia/hypercholesterolemia...

See More

Key Turning Points

3rd Resistance Point 335.83
2nd Resistance Point 324.17
1st Resistance Point 316.31
Last Price 308.44
1st Support Level 296.79
2nd Support Level 285.13
3rd Support Level 277.27

See More

52-Week High 368.29
Last Price 308.44
Fibonacci 61.8% 291.87
Fibonacci 50% 268.27
Fibonacci 38.2% 244.66
52-Week Low 168.25

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar